
Keywords: Polycystic ovaries syndrome; Hyperandrogenism; Insulin resistance; Genomic variant; Epigenetics; Environmental endocrine disruptors; Foetal programming; SOPK; Hyperandrogénie ovarienne; Insulino-résistance; Maturation folliculaire; Variant génétique;